Skip to main content
Caplight Logo









Strella Biotech

Strella Biotech

Private
Seattle, WashingtonFrontier & Industrial Techhttps://strellabiotech.com/

Last Round

Seed Round

Aug 14, 2026

Est. Valuation

$31.1M

Total Funding Raised

$11.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Strella Biotech is an agricultural technology company that provides proprietary biosensor technology fueled by Internet-of-Things capabilities to monitor the ripeness of fruit and reduce food waste in the supply chain.

Sector

Frontier & Industrial Tech

Verticals

Supply Chain, IoT Hardware, Environmental Monitoring, Quality Management

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

agtechbiosensing platformethylene monitoringfood waste reductionsupply chain optimizationautomated quality managementAQMIoT sensorspredictive analyticscontrolled atmosphere storagefresh produce supply chainsmart agriculturecold chain monitoringSaaSprecision agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Strella Biotech Comparables

Compare Strella Biotech with similar companies based on industry and business-model similarity.

Strella Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OneThird
81%
Zest Labs
78%
Ripe-Guard
77%

Strella Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 14, 2026
Series AJun 7, 2022
SeedApr 30, 2020
GrantApr 9, 2019

Strella Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 14, 2026

    Raised $1.76M in a seed funding round.

  • Jun 7, 2022

    $8M round led by Millennium Technology Value Partners.

Strella Biotech Filings

Explore SEC and related filing metadata, where available.

Strella Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Strella Biotech's valuation, stock price, and market status.

Is Strella Biotech a public or private company?

Strella Biotech is a private company.

What is the current stock price of Strella Biotech?

Strella Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Strella Biotech worth (valuation)?

Valuation information for Strella Biotech is not publicly available.

Can I buy Strella Biotech stock?

Strella Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Strella Biotech's last funding round?

Strella Biotech's most recent funding round was Series A on June 7, 2022.

Who are the main investors in Strella Biotech?

Key investors in Strella Biotech include Yamaha Motor Ventures, Millennium Technology Value Partners, Catapult Ventures.

Will Strella Biotech IPO soon?

No public IPO plans have been announced for Strella Biotech.

How can I track Strella Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Strella Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range26
Year Founded2018
Last FundingAug 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?